Year: 2019

Scientists at USC and UC San Diego have discovered a potential novel target for treating glioblastoma. “We think this is opening the door to a whole new range of therapies,” said Steve Kay. “It’s a great example of collaboration and convergence.” (August 27, 2019)…Continue Reading Can the circadian clock in cancer cells help defeat a deadly brain cancer?

Students attribute Fulbright opportunities to study diabetes and cancer to research experience gained at the Bridge Institute at the USC Michelson Center for Convergent Bioscience. (May 9, 2019)…Continue Reading 2 Bridge Institute BUGS grads finish with Fulbright fellowships in hand

Researchers plan to develop new sleep disorder treatments based on new 3D models of two melatonin receptors created by an international team. The studies were published in ‘Nature.’ (April 24, 2019)…Continue Reading A good night’s sleep may be in sight

The director of the USC Michelson Center for Convergent Bioscience and the MESH Academy becomes the university’s second faculty member in the prestigious society. (April 18, 2019)…Continue Reading Steve Kay elected to the Royal Society of London

Scientists at USC Michelson Center for Convergent Bioscience and Japan’s Nagoya University find and test a promising drug that stops cancer by interfering with the cancer cells’ metabolism and other circadian-related functions. (January 23, 2019)…Continue Reading Cancer has a biological clock and this drug may keep it from ticking

On NPR’s Joe’s Big Idea, Andrea Armani and Samantha McBirney explain the inspiration behind their work on malaria and their progress toward an inexpensive and effective early-detection device. (January 17, 2019)…Continue Reading Unmasking Malaria With A Cheap Magnet And A Laser Pointer